http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013023444-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a022923c14f9ca35441081d3af4a3ab1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
filingDate 2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b701f4fdd06b39344f08cbe48fd59295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f5738b4caca1bc512438f46765d058e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34fe805b713b28713603c5a1d6b6c444
publicationDate 2013-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013023444-A
titleOfInvention Tetravalent platinum complex and pharmaceutical composition containing the same
abstract A novel tetravalent platinum complex having strong antitumor activity against malignant tumors and relatively reduced side effects is provided. A tetravalent platinum complex having cis, cis-spiro [4,4] nonane-1,6-diamine, and an optically active diamine as a ligand, particularly represented by the following formula (G): A tetravalent platinum dichloromalonate complex comprising (S, S, S) -cis, cis-spiro [4,4] nonane-1,6diamine as a ligand. [Chemical 1] [Selection figure] None
priorityDate 2011-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010082503-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007662-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02108693-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010026711-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410492086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159247799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451005606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22066175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450407186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448536344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422731391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148243879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58321023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19820799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415760527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414661543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61856

Total number of triples: 50.